Intravitreal ranibizumab (Lucentis®) in the treatment of retinal angiomatous proliferation (RAP)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravitreal ranibizumab (Lucentis®) in the treatment of retinal angiomatous proliferation (RAP)

Published:2009-04-29 Issue:9 Volume:247 Page:1165-1171
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Konstantinidis Lazaros,Mameletzi Evangelia,Mantel Irmela,Pournaras Jean-Antoine,Zografos Leonidas,Ambresin Aude

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-009-1089-3.pdf

Reference37 articles.

1. Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D, Matsumoto Y, Sorenson JA, Yannuzzi L (2008) Type 3 neovascularization: The expanded spectrum of retinal angiomatous proliferation. Retina 28:201–211, doi: 10.1097/IAE.0b013e3181669504

2. Yannuzzi LA, Freund KB, Takahashi BS (2008) Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 28:375–384, doi: 10.1097/IAE.0b013e3181619c55

3. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, Freund KB, Sorenson J, Orlock D, Borodoker N (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416–434, doi: 10.1097/00006982-200110000-00003

4. Gross NE, Aizman A, Brucker A, Klancnik JM Jr, Yannuzzi LA (2005) Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 25:713–718, doi: 10.1097/00006982-200509000-00005

5. Bottoni F, Massacesi A, Cigada M, Viola F, Musicco I, Staurenghi G (2005) Treatment of retinal angiomatous proliferation in age-related macular degeneration: A series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123:1644–1650, doi: 10.1001/archopht.123.12.1644

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional and structural characteristics in patients with type 3 macular neovascularisation treated with anti-VEGF. Three-year results in real world settings;Eye;2024-01-06

2. Long-Term Treatment Outcomes in Type 3 Neovascularization: Focus on the Difference in Outcomes between Geographic Atrophy and Fibrotic Scarring;Journal of Clinical Medicine;2020-04-16

3. Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment;Graefe's Archive for Clinical and Experimental Ophthalmology;2019-04-01

4. Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization;International Journal of Ophthalmology;2019-03-18

5. Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months;British Journal of Ophthalmology;2018-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3